On 14 November the High Court granted an interim interdict in favour of pharmaceutical giant Bayer, preventing the generic manufacturer Pharma Dynamics from selling an oral contraceptive called Ruby. Big pharma is using South Africa's weak intellectual property laws to inject extra life into its drugs monopoly. And we see that healthcare regulations benefit monopolies, rather than the public.

Like to see more ?

While every reasonable effort is taken to ensure the accuracy and soundness of the contents of this publication, neither the authors nor the publishers of this website bear any responsibility for the consequences of any actions based on the information contained therein.